ScholarIQanswers from OpenAlex

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer

PaperCitations, authors & open-access status

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer have?

ScholarIQcitation count

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer has 369 citations in the OpenAlex counts ScholarIQ stores.

When was Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer published?

ScholarIQyear

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer has 2016 year in the ScholarIQ index.

What is the open-access status of Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer?

ScholarIQoa status

Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer?

ScholarIQdoi

The DOI for Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer is on the source record.

What is the PMID of Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer?

ScholarIQpmid

The PMID for Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer is on the source record.

What is the OpenAlex record for Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer?

ScholarIQopenalex

The OpenAlex for Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial